BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/12/2026 1:58:29 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-03-18 07:19 |
|
Peer-Review Started |
|
2026-03-18 07:20 |
|
First Decision by Editorial Office Director |
|
2026-04-23 03:46 |
|
Return for Revision |
|
2026-04-23 03:46 |
|
Revised |
|
2026-07-02 10:08 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-07-06 08:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-07-06 08:39 |
|
Articles in Press |
|
2026-07-06 08:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-08-07 00:34 |
|
Publish the Manuscript Online |
|
2026-08-12 01:58 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Umbilical cord mesenchymal stem cells in diabetes mellitus
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gumpeny R Sridhar, Suresh Anne, Lakshmi Gumpeny and Sanjana S N Narasimhadevara |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gumpeny R Sridhar, Department of Endocrinology and Diabetes, Endocrine and Diabetes Centre, 15-12-15 Krishnanagar, Visakhapatnam 530002, India. sridharvizag@gmail.com |
| Key Words |
Pancreatic transplantation; Immunotherapy; Cell replacement; Extracellular vesicles; Immunomodulation; Pre-clinical; Biobanking; Regulations; Cost benefit |
| Core Tip |
Umbilical cord mesenchymal stem cells have the potential to modify the course of diabetes mellitus, eventually leading to its possible cure. They regulate immune destruction of pancreatic b cell and can also regenerate them. Animal studies showed their effectiveness. Early human reports showed positive results. Larger long term human randomized clinical trials are needed to bring prospect to practice. |
| Publish Date |
2026-08-12 01:58 |
| Citation |
Sridhar GR, Anne S, Gumpeny L, Narasimhadevara SSN. Umbilical cord mesenchymal stem cells in diabetes mellitus. World J Clin Cases 2026; 14(23): 121196
|
| URL |
https://www.wjgnet.com/2307-8960/full/v14/i23/121196.htm |
| DOI |
https://doi.org/10.12998/wjcc.121196 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
